$42.36 -$0.25 (-0.6%)

04:00 PM EST on 11/21/19

Boston Scientific Corp. (NYSE:BSX)

CAPS Rating: 4 out of 5

The Company develops, manufactures & markets medical devices that are used in interventional cardiology, peripheral interventions, vascular surgery, electrophysiology, neurovascular intervention, oncology, endoscopy, urology, gynecology & neuromodulation.

Current Price $42.36 Mkt Cap $59.4B
Open $42.49 P/E Ratio 54.30
Prev. Close $42.61 Div. (Yield) $0.00 (0.0%)
Daily Range $41.88 - $42.49 Volume 1,149,049
52-Wk Range $32.74 - $43.83 Avg. Daily Vol. 7,922,247

Caps

How do you think NYSE:BSX will perform against the market?

Add Stock to CAPS Watchlist

All Players

741 Outperform
187 Underperform
 

All-Star Players

164 Outperform
16 Underperform
 

Wall Street

21 Outperform
2 Underperform
 

Top NYSE:BSX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFBreakerJava (99.74)
Submitted July 12, 2009

They are generating lots of cash and rapidly paying down debt. Insider selling last fall was induced by the financial crisis and does not reflect a lack of faith in the business. Gross margin of 70%. They will likely benefit from universal health… More

dickshatband (< 20)
Submitted March 15, 2010

Another major blunder from a company that knows all to well the consequences of such a major mistake. Please take my advice when I tell you this ship is sinking fast.

Recent Community Commentary

Read the most recent pitches from players about BSX.

Recs

0
Member Avatar plowboy (< 20) Submitted: 2/1/2014 1:58:59 PM : Outperform Start Price: $13.55 NYSE:BSX Score: +138.22

turnaround

Recs

0
Member Avatar simonwmich (< 20) Submitted: 1/18/2014 5:36:14 PM : Outperform Start Price: $13.82 NYSE:BSX Score: +138.49

Stock has almost tripled over the past year and game changing technologies forthcoming with 1H14 expected launch of Watchman A Fib device. Company could also benefit the most from MDT Simplicity renal denervation failure.

Recs

0
Member Avatar hammerpants (< 20) Submitted: 4/12/2013 1:16:47 AM : Outperform Start Price: $7.68 NYSE:BSX Score: +355.99

Bsx has been the red headed stepchild for too long. Sure - interventional cardiology and crm isn't as glamorous as it once was, but there is still plenty of lettuce to be made. Business is finally leaner and out from under a lot of dead weight and regulatory trouble, still some improvements to go, but solid sales and distribution channels are there. A few technology breakthroughs or acquisitions away from blowing it away.

Leaderboard

Find the members with the highest scoring picks in BSX.

Score Leader

Boum

Boum (< 20) Score: +620.22

The Score Leader is the player with the highest score across all their picks in BSX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Boum < 20 7/26/2012 Outperform 5Y $4.99 +748.90% +128.68% +620.22 0 Comment
akim088 < 20 7/27/2012 Outperform 1Y $5.02 +743.82% +126.71% +617.12 1 Comment
morten1952 84.78 10/25/2012 Outperform 5Y $5.15 +722.52% +118.52% +604.01 0 Comment
eljuden21 72.61 7/30/2012 Outperform 1Y $5.18 +717.76% +124.04% +593.72 0 Comment
TessaFaye 73.51 1/4/2012 Outperform 5Y $5.32 +696.24% +143.98% +552.26 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. adamotocross48 72.60 12/12/2011 7/25/2013 Outperform 3Y $5.32 +696.24% +148.37% +547.87 0 Comment
lusito1779 < 20 1/13/2012 Outperform 5Y $5.45 +677.25% +141.75% +535.49 0 Comment
StudlyDoRight < 20 9/2/2010 Outperform 5Y $5.18 +717.76% +185.29% +532.47 0 Comment
ttodisco < 20 6/27/2012 Outperform 1Y $5.55 +663.24% +134.36% +528.88 1 Comment
BooBearsDad < 20 10/26/2011 Outperform 3M $5.44 +679.39% +152.25% +527.15 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for BSX.